Company profile: Accel Research Sites
1.1 - Company Overview
Company description
- Provider of multi-therapeutic clinical research services, conducting clinical trials across various medical conditions; centralized recruitment; project management for study startup and performance to ensure streamlined processes and quality assurance across sites; and Phase 1 trial facilities, including inpatient trials with specialized capabilities in oncology and other areas.
Products and services
- Centralized Recruitment: Engineers a centralized, database-driven recruitment strategy that efficiently enrolls clinical trial participants by leveraging site-level assets and a robust patient database
- Clinical Trials: Delivers multi-therapeutic access to investigational treatments across various medical conditions, enabling participants to access novel therapies and contribute to medical research
- Phase 1 Trials: Supplies inpatient-capable facilities for early-phase studies, including Phase 1 inpatient trials with specialized capabilities in oncology and other areas
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Accel Research Sites
Coldchain Tech
HQ: United States
Website
- Description: Provider of cold chain management solutions for temperature-sensitive products, including VIP Shipping Systems with customizable -40°C to +70°C control; Sentry Monitoring Technology for 24/7 real-time tracking and compliance; emergency preparedness logistics and packaging; reusable thermal shippers; end-to-end fulfillment services; and SHIP2Q for hygienic, sustainable transport with component reuse.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coldchain Tech company profile →
Galenicum
HQ: Spain
Website
- Description: Provider of pharmaceutical products and services, including R&D, regulatory affairs, manufacturing, licensing, and global supply across technologies from injectables to oral solids and nasal sprays. Operates a facility near Madrid producing over 50 million packs annually, trades APIs, and markets Vitae bioequivalent medicines and Galenicum Derma specialty dermatology products; applies QbD standards in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Galenicum company profile →
CRO Kottmann
HQ: Germany
Website
- Description: Provider of contract research services specializing in customer service, scientific clinical research, and quality.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CRO Kottmann company profile →
Greenleaf Health
HQ: United States
Website
- Description: Provider of consulting services and guidance on FDA regulatory compliance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Greenleaf Health company profile →
BioClin Labs
HQ: Ireland
Website
- Description: Provider of internationally recognised expert analytical services and rapid reporting of data to support drug development and product release, leveraging breadth of scientific experience and knowledge across a wide range of techniques to develop optimal methods that run efficiently and meet regulatory.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioClin Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Accel Research Sites
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Accel Research Sites
2.2 - Growth funds investing in similar companies to Accel Research Sites
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Accel Research Sites
4.2 - Public trading comparable groups for Accel Research Sites
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →